ABHD6 and nervous system disorder: Compared with inhibition of MAGL, also a potential target for inflammatory disease (Deng and Li, 2020a), ABHD6 inhibition has fewer side effects (detailed in subsection 5, ABHD6 and Neurological Diseases).